Burden of disease and unmet needs in tuberous sclerosis complex with neurological manifestations: systematic review

2011 ◽  
Vol 27 (8) ◽  
pp. 1571-1583 ◽  
Author(s):  
Lindsay Hallett ◽  
Talia Foster ◽  
Zhimei Liu ◽  
Marissa Blieden ◽  
Joice Valentim
2015 ◽  
Vol 80 ◽  
pp. 70-79 ◽  
Author(s):  
Bo Zhang ◽  
Jia Zou ◽  
Nicholas R. Rensing ◽  
Meihua Yang ◽  
Michael Wong

2020 ◽  
Vol 15 (1) ◽  
Author(s):  
Johann Philipp Zöllner ◽  
David Neal Franz ◽  
Christoph Hertzberg ◽  
Rima Nabbout ◽  
Felix Rosenow ◽  
...  

2008 ◽  
Vol 8 (6) ◽  
pp. 159-162 ◽  
Author(s):  
Peter B. Crino

The recent development of several mouse models for tuberous sclerosis complex (TSC) provides in vivo systems to test new therapies for the neurological manifestations of TSC. Rapamycin is known to antagonize the effects of loss of TSC protein function in vitro and in mouse TSC models, rapamycin can prevent seizures and improve learning task performance. These findings provide new hope for TSC patients suffering from intractable seizures and possibly, for those with autism and cognitive disabilities.


2013 ◽  
Vol 105 (3) ◽  
pp. 377-383 ◽  
Author(s):  
Kai Zhang ◽  
Wen-han Hu ◽  
Chao Zhang ◽  
Fan-gang Meng ◽  
Ning Chen ◽  
...  

CNS Drugs ◽  
1995 ◽  
Vol 3 (3) ◽  
pp. 174-185 ◽  
Author(s):  
Richard E. Appleton ◽  
Alan E. Fryer

2020 ◽  
Author(s):  
Mehdi Chihi ◽  
Ulrich Sure ◽  
Ramazan Jabbarli

To date, little is known on the prevalence, incidence, and characteristics of intracranial aneurysms (IA) in patients with tuberous sclerosis complex (TSC). Based on our recent systematic review and two cases treated in our institute, we summarize the current evidence concerning the distinct characteristics of these aneurysms. In contrast to saccular IA in healthy adults, IA in TSC present commonly with large or even giant sac size and fusiform configuration, location predilection on the internal carotid artery remote from the branching zones, remarkable higher prevalence of pediatric cases, inverted sex-ratio, and suspected rapid growth. Although the pathogenesis of IA in TSC is still unclear, all these features might point to the crucial role a congenital defect in the development of IA rather than extrinsic or environmental factors. Furthermore, we discuss the enhancement of the regular magnetic resonance (MR) imaging screening suggested by the last recommendations of the 2012 International TSC Consensus Conference with cranial time-of-flight MR angiography in order to enable timely identification and treatment of frequently complex IA in TSC.


2019 ◽  
Vol 127 ◽  
pp. 390-397 ◽  
Author(s):  
Shu-ichi Okamoto ◽  
Olga Prikhodko ◽  
Juan Pina-Crespo ◽  
Anthony Adame ◽  
Scott R. McKercher ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document